Literature DB >> 17392820

Thrombosis can occur at any phase of essential thrombocythemia with JAK2(V617F) mutation: a single institutional study in Japan.

K Ohyashiki, Y Ito, K Hori, K Sato, T Makino, J H Ohyashiki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17392820     DOI： 10.1038/sj.leu.2404666

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.

Authors:  Kazuma Ohyashiki; Toru Kiguchi; Yoshikazu Ito; Hiroaki Fujimoto; Akihiko Gotoh; Tetsuzo Tauchi; Keisuke Miyazawa; Yukihiko Kimura; Junko H Ohyashiki
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

2.  The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.

Authors:  Youwen Qin; Xiaorui Wang; Chuxian Zhao; Chun Wang; Yining Yang
Journal:  Int J Hematol       Date:  2015-05-22       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.